BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27190317)

  • 1. Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.
    Dandri M; Petersen J
    Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S281-8. PubMed ID: 27190317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of cccDNA in HBV Maintenance.
    Allweiss L; Dandri M
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting Hepatitis B Virus: Challenges of Curative Therapies.
    Hu J; Protzer U; Siddiqui A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection.
    Gómez-Moreno A; Garaigorta U
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29048354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.
    Cui X; Guo JT; Hu J
    J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulation in chronic hepatitis B virus infection.
    Dandri M
    Semin Immunopathol; 2020 Apr; 42(2):173-185. PubMed ID: 32185454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
    Kitamura K; Que L; Shimadu M; Koura M; Ishihara Y; Wakae K; Nakamura T; Watashi K; Wakita T; Muramatsu M
    PLoS Pathog; 2018 Jun; 14(6):e1007124. PubMed ID: 29928064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.
    Singh P; Kairuz D; Arbuthnot P; Bloom K
    World J Gastroenterol; 2021 Jun; 27(23):3182-3207. PubMed ID: 34163105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immortalized Hepatocyte-like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV.
    Sa-Ngiamsuntorn K; Thongsri P; Pewkliang Y; Wongkajornsilp A; Kongsomboonchoke P; Suthivanich P; Borwornpinyo S; Hongeng S
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31623162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Editing Technologies to Target HBV cccDNA.
    Martinez MG; Smekalova E; Combe E; Gregoire F; Zoulim F; Testoni B
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV-Integration Studies in the Clinic: Role in the Natural History of Infection.
    Pollicino T; Caminiti G
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33652619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.
    Ohno M; Otsuka M; Kishikawa T; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jun; 21(23):7084-8. PubMed ID: 26109795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus.
    Kaneko S; Kakinuma S; Asahina Y; Kamiya A; Miyoshi M; Tsunoda T; Nitta S; Asano Y; Nagata H; Otani S; Kawai-Kitahata F; Murakawa M; Itsui Y; Nakagawa M; Azuma S; Nakauchi H; Nishitsuji H; Ujino S; Shimotohno K; Iwamoto M; Watashi K; Wakita T; Watanabe M
    Sci Rep; 2016 Jul; 6():29358. PubMed ID: 27386799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Transcription Factors in Hepatitis B Virus RNA Synthesis.
    Turton KL; Meier-Stephenson V; Badmalia MD; Coffin CS; Patel TR
    Viruses; 2020 Jan; 12(2):. PubMed ID: 32019103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological Basis for the Cure of Chronic Hepatitis B.
    Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT
    ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the Interactions of HBV cccDNA with Host Factors.
    Mohd-Ismail NK; Lim Z; Gunaratne J; Tan YJ
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
    Schreiner S; Nassal M
    Viruses; 2017 May; 9(5):. PubMed ID: 28531167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.